X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7) 7
female (6) 6
index medicus (5) 5
lymphomas (5) 5
male (5) 5
adult (4) 4
middle aged (4) 4
aged (3) 3
aged, 80 and over (3) 3
cancer (3) 3
medicine & public health (3) 3
article (2) 2
classification (2) 2
diffuse large b-cell lymphoma (2) 2
discovery (2) 2
disease-free survival (2) 2
drug therapy (2) 2
expression (2) 2
finland - epidemiology (2) 2
gene expression (2) 2
gene expression profiling (2) 2
genome (2) 2
immunohistochemistry (2) 2
lymphoma (2) 2
medical research (2) 2
multivariate analysis (2) 2
non-hodgkins-lymphoma (2) 2
oncology (2) 2
pathology (2) 2
prognosis (2) 2
rituximab (2) 2
somatic mutations (2) 2
survival (2) 2
111 (1) 1
157 (1) 1
176 (1) 1
3125 otorhinolaryngology, ophthalmology (1) 1
abridged index medicus (1) 1
activated b-cell-like (1) 1
activation (1) 1
adjuvant (1) 1
aid (1) 1
algorithms (1) 1
analysis (1) 1
animals (1) 1
ann arbor classification (1) 1
antibodies, monoclonal - administration & dosage (1) 1
antibodies, monoclonal, murine-derived (1) 1
antibodies, monoclonal, murine-derived - therapeutic use (1) 1
antimetabolites - pharmacology (1) 1
antimetabolites - therapeutic use (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
antioxidants (1) 1
antioxidants - metabolism (1) 1
automobile drivers (1) 1
b-cell lymphoma (1) 1
b-lymphocytes - immunology (1) 1
b-lymphocytes - pathology (1) 1
bcl-2 (1) 1
biochemistry & molecular biology (1) 1
biomarkers - blood (1) 1
biomarkers, tumor - analysis (1) 1
biomarkers, tumor - blood (1) 1
bisphosphonate (1) 1
bisphosphonates inhibit (1) 1
bone neoplasms - prevention & control (1) 1
bone neoplasms - secondary (1) 1
bone-mineral density (1) 1
breast cancer (1) 1
breast neoplasms - diagnosis (1) 1
breast neoplasms - drug therapy (1) 1
breast neoplasms - mortality (1) 1
breast neoplasms - secondary (1) 1
cancer and oncology (1) 1
cancer och onkologi (1) 1
cancer therapies (1) 1
carcinoma (1) 1
care and treatment (1) 1
cell (1) 1
cell biology (1) 1
cell line, tumor (1) 1
cell lung-cancer (1) 1
cells, cultured (1) 1
cervical cancer (1) 1
chemotherapy (1) 1
chemotherapy improves (1) 1
chemotherapy plus rituximab (1) 1
chemotherapy, adjuvant (1) 1
chop (1) 1
clinical medicine (1) 1
clinical neurology (1) 1
clinical trials (1) 1
clodronic acid - pharmacology (1) 1
clodronic acid - therapeutic use (1) 1
crispr-cas systems (1) 1
cyclophosphamide (1) 1
cyclophosphamide - therapeutic use (1) 1
deficiency (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2011, Volume 377, Issue 9759, pp. 42 - 51
Journal Article
Modern Pathology, ISSN 0893-3952, 08/2009, Volume 22, Issue 8, pp. 1094 - 1101
Gene expression profiling studies initially enabled diffuse large B-cell lymphoma to be divided into germinal center and activated B-cell-like subtypes, which... 
Prognosis | Activated B-cell-like | MUM1/IRF4 | R-CHOP | Diffuse large B-cell lymphoma | GERMINAL CENTER TYPE | diffuse large B-cell lymphoma | PATHOLOGY | prognosis | BCL-2 | activated B-cell-like | GENE | CHEMOTHERAPY IMPROVES | RITUXIMAB | PREDICTS SURVIVAL | TISSUE MICROARRAY | ELDERLY-PATIENTS | EXPRESSION | IMMUNOHISTOCHEMISTRY | Immunohistochemistry | Doxorubicin - therapeutic use | Humans | Gene Expression Profiling | Neprilysin - biosynthesis | Cyclophosphamide - therapeutic use | Lymphocyte Activation - immunology | Interferon Regulatory Factors - biosynthesis | Lymphoma, Large B-Cell, Diffuse - immunology | Neprilysin - genetics | Prednisolone - therapeutic use | B-Lymphocytes - pathology | Forkhead Transcription Factors - biosynthesis | Gene Expression | Antibodies, Monoclonal, Murine-Derived | Lymphoma, Large B-Cell, Diffuse - pathology | Biomarkers, Tumor - analysis | Kaplan-Meier Estimate | Interferon Regulatory Factors - genetics | Repressor Proteins - genetics | Rituximab | DNA-Binding Proteins - genetics | Forkhead Transcription Factors - genetics | Proto-Oncogene Proteins c-bcl-2 - biosynthesis | Phenotype | Algorithms | B-Lymphocytes - immunology | Repressor Proteins - biosynthesis | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Lymphoma, Large B-Cell, Diffuse - classification | Vincristine - therapeutic use | DNA-Binding Proteins - biosynthesis | Proto-Oncogene Proteins c-bcl-2 - genetics | Proto-Oncogene Proteins c-bcl-6 | Index Medicus | Clinical Medicine | Medical and Health Sciences | Medicin och hälsovetenskap | Klinisk medicin | Cancer and Oncology | Cancer och onkologi
Journal Article
Leukemia, ISSN 0887-6924, 2019, Volume 33, Issue 11, pp. 2662 - 2672
Diffuse large B-cell lymphoma (DLBCL) is a biologically and clinically heterogeneous disease whose personalized clinical management requires robust molecular... 
SURVIVAL | SIGNATURES | ONCOLOGY | CLASSIFICATION | TARGETS | CHOP | AID | HEMATOLOGY | CHEMOTHERAPY PLUS RITUXIMAB | SOMATIC MUTATIONS | DISCOVERY | GENOME | Target recognition | Therapeutic applications | Genes | Gene expression | Multivariate analysis | Lymphoma | Disease control | Survival | Exploitation | Somatic hypermutation | Lymphocytes B | Classification | Lymphomas | B-cell lymphoma
Journal Article
Cell, ISSN 0092-8674, 10/2017, Volume 171, Issue 2, pp. 481 - 494.e15
Journal Article
Modern Pathology, ISSN 0893-3952, 05/2010, Volume 23, Issue 5, p. 686
  Development of targeted agents for the treatment of diffuse large B-cell lymphoma includes clinical evaluation of enzastaurin, an agent that suppresses... 
Journal Article
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.